(Reuters) -AbbVie said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been demanding that drugmakers align ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback